| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.87B | 51.28B | 49.96B | 46.28B | 46.48B | 45.43B |
| Gross Profit | 54.87B | 48.82B | 49.20B | 45.86B | 46.11B | 44.99B |
| EBITDA | 7.27B | 12.30B | 11.53B | 11.35B | 10.54B | 9.32B |
| Net Income | 8.16B | 7.46B | 7.43B | 6.48B | 6.38B | 4.76B |
Balance Sheet | ||||||
| Total Assets | 3.33T | 3.25T | 3.23T | 3.18T | 3.57T | 3.25T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 244.52B | 259.06B | 261.92B | 685.73B | 359.42B |
| Total Debt | 35.65B | 35.81B | 27.22B | 21.83B | 841.55B | 149.84B |
| Total Liabilities | 3.15T | 3.07T | 3.04T | 3.01T | 3.40T | 3.07T |
| Stockholders Equity | 173.41B | 170.15B | 182.66B | 166.60B | 171.73B | 178.85B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 17.55B | -1.19B | -432.26B | 0.00 | 253.86B |
| Operating Cash Flow | 0.00 | 18.58B | 591.00M | -430.23B | 0.00 | 256.03B |
| Investing Cash Flow | 0.00 | -55.85B | -12.79B | 10.81B | 2.33B | -28.05B |
| Financing Cash Flow | 0.00 | 22.80B | 26.79B | -389.05B | 45.75B | -1.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥364.60B | 7.80 | ― | 1.95% | 19.69% | 50.61% | |
75 Outperform | ¥1.54T | 12.46 | 7.38% | 2.62% | 15.86% | 24.81% | |
71 Outperform | ¥268.71B | 14.45 | ― | 2.13% | 7.77% | 5.80% | |
70 Outperform | ¥233.28B | 8.55 | ― | 3.00% | 10.56% | 16.02% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥131.11B | 9.42 | ― | 0.58% | 15.03% | 16.66% | |
64 Neutral | ¥1.17T | 11.66 | ― | 2.00% | 18.45% | 41.89% |